Literature DB >> 15592137

The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls.

David P Graham1, Jeffrey A Cully, A Lynn Snow, Paul Massman, Rachelle Doody.   

Abstract

The Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-cog) is commonly used to assess cognitive dysfunction in individuals with Alzheimer disease and other dementias. The purpose of this study was to provide normative scores for the ADAS-cog 11 individual items and total score, as well for delayed recall errors, using normal, elderly volunteers. The ADAS-cog was administered to 124, non-cognitively impaired volunteers ages 55 to 89, with 10 to 21 years of education. The mean total ADAS-cog score was five. The ADAS-cog error score was not associated with education in this highly educated group, and was positively correlated (P < 0.001) with the age of the participant. Age stratified ADAS-cog normative data are reported for the ADAS-cog total and the delayed recall error score.

Entities:  

Mesh:

Year:  2004        PMID: 15592137

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  26 in total

Review 1.  Clinical trials in mild cognitive impairment: lessons for the future.

Authors:  V Jelic; M Kivipelto; B Winblad
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11-23       Impact factor: 10.154

2.  Identifying amnestic mild cognitive impairment in primary care: a feasibility study.

Authors:  Rachelle S Doody; Steven H Ferris; Stephen Salloway; Thomas M Meuser; Anita K Murthy; Chunming Li; Robert Goldman
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

3.  A study of medication-taking and unobtrusive, intelligent reminding.

Authors:  Tamara L Hayes; Kofi Cobbinah; Terry Dishongh; Jeffrey A Kaye; Janna Kimel; Michael Labhard; Todd Leen; Jay Lundell; Umut Ozertem; Misha Pavel; Matthai Philipose; Kevin Rhodes; Sengul Vurgun
Journal:  Telemed J E Health       Date:  2009-10       Impact factor: 3.536

4.  Relations between cognitive status and medication adherence in patients treated for memory disorders.

Authors:  Raymond L Ownby; Christopher Hertzog; Sara J Czaja
Journal:  Ageing Res       Date:  2012-09-01

5.  Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease.

Authors:  Kolbjorn Bronnick; Murat Emre; Roger Lane; Sibel Tekin; Dag Aarsland
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-07       Impact factor: 10.154

6.  Medication adherence in healthy elders: small cognitive changes make a big difference.

Authors:  Tamara L Hayes; Nicole Larimer; Andre Adami; Jeffrey A Kaye
Journal:  J Aging Health       Date:  2009-04-01

7.  Tailored Information and Automated Reminding to Improve Medication Adherence in Spanish- and English-Speaking Elders Treated for Memory Impairment.

Authors:  Raymond L Ownby; Christopher Hertzog; Sara J Czaja
Journal:  Clin Gerontol       Date:  2012-05-01       Impact factor: 2.619

Review 8.  [Hearing and cognition: neurocognitive test batteries in otorhinolaryngology].

Authors:  C Völter; L Götze; U Bruene-Cohrs; S Dazert; J P Thomas
Journal:  HNO       Date:  2020-03       Impact factor: 1.284

9.  Higher motor cortical excitability linked to greater cognitive dysfunction in Alzheimer's disease: results from two independent cohorts.

Authors:  Siddhesh Zadey; Stephanie S Buss; Katherine McDonald; Daniel Z Press; Alvaro Pascual-Leone; Peter J Fried
Journal:  Neurobiol Aging       Date:  2021-06-24       Impact factor: 4.673

10.  Study of Mental Activity and Regular Training (SMART) in at risk individuals: a randomised double blind, sham controlled, longitudinal trial.

Authors:  Nicola J Gates; Michael Valenzuela; Perminder S Sachdev; Nalin A Singh; Bernhard T Baune; Henry Brodaty; Chao Suo; Nidhi Jain; Guy C Wilson; Yi Wang; Michael K Baker; Dominique Williamson; Nasim Foroughi; Maria A Fiatarone Singh
Journal:  BMC Geriatr       Date:  2011-04-21       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.